Navigation Links
Remedy Informatics CEO, Gary Kennedy, to Speak at Molecular Med TRI-CON
Date:2/16/2012

SALT LAKE CITY, Feb. 16, 2012  /PRNewswire/ -- Remedy Informatics, the leading provider of integrated research management systems for Life Science and Translational research, announced that its Founder and CEO, Gary Kennedy, will participate as a speaker in the Integrated R&D Informatics and Knowledge Management Track on Tuesday, Feb. 21, and as an expert panelist on Wednesday, Feb. 22 at Molecular Med TRI-CON Feb. 19-23, 2012, in San Francisco, Calif. (Booth #604).

(Logo: http://photos.prnewswire.com/prnh/20120206/SF47874LOGO)

Mr. Kennedy's presentation on Tuesday, titled, "Aggregating & Harmonizing Disparate Data Sources: The Key to Pattern Recognition," will address the fundamental data problems faced by life science and translational researchers – integrating research systems and breaking down silos, generating complete and accurate data sets, and making data accessible with easy-to-use pattern recognition tools. He will also describe how modern ontology-based informatics systems hosted in the cloud can provide a competitive advantage via predictive informatics.

The plenary keynote panel on Wednesday, titled, "Emerging Technologies & Industry Perspectives," will offer conference attendees a look at "emerging and hot technologies in diagnostics, drug discovery and development, informatics, and oncology." A Q&A discussion will also provide attendees an opportunity to interact with panel members.

More information regarding Mr. Kennedy's talk or the expert panel discussion is available on the Molecular Med TRI-CON website, www.triconference.com.

Remedy will also demo Investigate™, the world's first integrated translational research management system at the conference. The product will be featured in the New Product Pavilion at Molecular Med TRI-CON.

"Investigate is designed to improve research efficiencies, facilitate pattern recognition and accelerate discoveries in translational research settings," said Hank Wu, Director of Translational Informatics and Investigate product manager for Remedy.

Investigate is a unique tool available to translational researchers because it integrates next-generation sequencing systems with patient and disease registries and biospecimen management. Researchers benefit from:

  • Aggregation of disparate data types from bench to bedside data sources with an intelligent ontology that harmonizes biospecimen, registry and outcomes data
  • 360 degrees perspective of phenotypic and genotypic data for subjects, patients, diseases
  • Configurability that keeps up with the pace of research, without waiting for software coding or database administration
  • Multi-site, cross disease research collaboration without the cost and complexity of infrastructure building and maintenance
  • A suite of reporting, analysis, and data visualization tools that enable drag-and-drop reporting by researchers, scientists, and clinicians without writing SQL

Investigate was recently selected by SAIC-Frederick, Inc., the operations contractor for the National Cancer Institute's Frederick, Md. campus, as the research informatics platform for ten high profile cancer research laboratories to integrate lab information management systems (LIMS), study design and tracking, patient registries, and data mining and visualization.

Remedy will demonstrate Investigate at BOOTH #604 at the Molecular Med TRI-CON 2012 conference in San Francisco, Calif. beginning Feb. 21 – Feb. 23.

About Remedy Informatics, Inc.

Remedy Informatics, Inc. is the leading provider of clinical registries, integrated research management software, and research informatics products that accelerate translational medicine discoveries from bench to bedside. Remedy offers a wide range of configurable "off the shelf" biomedical informatics products that are built on the powerful Mosaic™ Platform. Remedy's mission is to tangibly, measurably and permanently improve the effectiveness of Life Science and Translational Research in the United States and across the globe.  For more information visit: www.remedyinformatics.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Mike Cummens
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=106822

Gary Kennedy
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=106824

Hank Wu
https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=106850

Media Contacts
Kristofer Beldin, Remedy Informatics, (801) 870-9407 (cell), kris.beldin@remedyinformatics.com


'/>"/>
SOURCE Remedy Informatics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
2. Fresenius Medical Care, N.A. Has Selected VitalRemedyMDs VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients
3. Cold-EEZE® Cold Remedy Awarded Coveted Parent Tested Parent Approved (PTPA) Seal of Approval
4. Cold-EEZE® Cold Remedy Announces Winners in its "Share Your Cause Not Your Cold" Campaign
5. RemedyMD Announces Investigate Cell Therapy, a Revolutionary Research Management System for Blood and Marrow Transplant Centers
6. Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
7. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
8. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
9. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
10. Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials
11. FUJIFILM Establishes Medical Informatics Organization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ALEX , has taken Kickstarter by storm, crowdfunding over $60,000 – or 120% of its original ... to be delivered to backers starting May of this year. ... ... ... Created by NAMU, a team of biomedical engineers out of ...
(Date:2/11/2016)... ROLLING MEADOWS , Ill. and INDIANAPOLIS ... major milestone for many young people, but for those ... demanding. Not only do these students juggle class schedules, ... challenges of living with type 1 diabetes. On top ... the first time. Diabetes Scholars Foundation ...
(Date:2/11/2016)... Feb. 11, 2016  AbbVie, a global biopharmaceutical ... Scholarship, designed to provide financial support for exceptional ... pursue higher education goals. Fifteen scholars will be ... school year. The AbbVie Rheumatology Scholarship is currently ... vice president, corporate social responsibility, brand and communications, ...
Breaking Medicine Technology:
(Date:2/11/2016)... , ... February 12, 2016 , ... The Journal ... up from 0.416 in 2013. The SJR uses data taken from the Scopus database ... both the number of citations received by the journal over a three year period ...
(Date:2/11/2016)... ... February 11, 2016 , ... Hall Integrative Health and ... for their simultaneous grand openings in March. All seven practices are set to ... wondering, is reversing diabetes possible? According to this 2011 CNN article it is ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study for Plans and ... health care system that’s partnering with Intel on value-based health benefits program Connected ...
(Date:2/11/2016)... ... , ... PharmMD CEO Robert Yeager announced today ... contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include healthcare ... breaches for the Part D Star Rating improvement and Medication Therapy Management firm. ...
(Date:2/11/2016)... Long Island, NY (PRWEB) , ... February 11, ... ... (INS) has enhanced and updated its hallmark resource, Infusion Therapy Standards of Practice, ... global leader in vein illumination with an estimated 85% share of the market, ...
Breaking Medicine News(10 mins):